1. Home
  2. XOMA vs UPXI Comparison

XOMA vs UPXI Comparison

Compare XOMA & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • UPXI
  • Stock Information
  • Founded
  • XOMA 1981
  • UPXI 2018
  • Country
  • XOMA United States
  • UPXI United States
  • Employees
  • XOMA N/A
  • UPXI N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • UPXI Medicinal Chemicals and Botanical Products
  • Sector
  • XOMA Health Care
  • UPXI Health Care
  • Exchange
  • XOMA Nasdaq
  • UPXI Nasdaq
  • Market Cap
  • XOMA 330.2M
  • UPXI 481.8M
  • IPO Year
  • XOMA N/A
  • UPXI 2021
  • Fundamental
  • Price
  • XOMA $32.47
  • UPXI $7.23
  • Analyst Decision
  • XOMA Strong Buy
  • UPXI
  • Analyst Count
  • XOMA 2
  • UPXI 0
  • Target Price
  • XOMA $69.50
  • UPXI N/A
  • AVG Volume (30 Days)
  • XOMA 57.0K
  • UPXI 8.1M
  • Earning Date
  • XOMA 08-13-2025
  • UPXI 05-16-2025
  • Dividend Yield
  • XOMA N/A
  • UPXI N/A
  • EPS Growth
  • XOMA N/A
  • UPXI N/A
  • EPS
  • XOMA N/A
  • UPXI N/A
  • Revenue
  • XOMA $44,952,000.00
  • UPXI $16,562,327.00
  • Revenue This Year
  • XOMA $82.30
  • UPXI $299.03
  • Revenue Next Year
  • XOMA $12.59
  • UPXI N/A
  • P/E Ratio
  • XOMA N/A
  • UPXI N/A
  • Revenue Growth
  • XOMA 194.98
  • UPXI 1378.83
  • 52 Week Low
  • XOMA $18.35
  • UPXI $1.90
  • 52 Week High
  • XOMA $35.23
  • UPXI $22.57
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 61.79
  • UPXI 51.85
  • Support Level
  • XOMA $32.60
  • UPXI $6.16
  • Resistance Level
  • XOMA $34.60
  • UPXI $9.12
  • Average True Range (ATR)
  • XOMA 1.82
  • UPXI 0.97
  • MACD
  • XOMA 0.09
  • UPXI 0.10
  • Stochastic Oscillator
  • XOMA 66.75
  • UPXI 47.86

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About UPXI Upexi Inc.

Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via a Solana treasury strategy.

Share on Social Networks: